Relationship between the risk score of the lncRNA signature for OS and clinical features.
Low risk/high risk | Pearson χ2 | ||
---|---|---|---|
Age | 0.072 | 0.788 | |
> = 55 | 119/116 | ||
< 55 | 53/55 | ||
Gender | 3.565 | 0.059 | |
Female | 47/63 | ||
Male | 125/108 | ||
TNM stage | 8.404 | 0.004 | |
I/II | 130/108 | ||
III/IV | 30/53 | ||
G | 12.032 | 0.001 | |
G1/G2 | 123/91 | ||
G3/G4 | 47/77 | ||
AFP (ng/ml) | 5.917 | 0.015 | |
> = 20 | 58/94 | ||
< 20 | 64/57 | ||
BMI | 0.213 | 0.645 | |
> =25 | 80/73 | ||
< 25 | 81/82 | ||
Race | 0.268 | 0.605 | |
White | 83/86 | ||
Asian | 77/71 |